Yamamoto et al. utilized direct hemoperfusion treatment with specific immunosuppressive substance adsorption columns for TGF-β ablation in rats bearing a TGF-β-producing hepatocellular carcinoma. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.